Understanding the mechanisms of mucin O-glycans degradation and utilization by microbiota members can reveal key enzymes that are potential drug targets in diseases associated with the increase of bacterial foraging on mucins and the disruption of the protective colonic mucus layers, such as IBD, obesity and colorectal cancer. The gene discussed is MUC5AC; the disease is inflammatory bowel disease.